Kui Zhao

2.3k citations
65 papers · 1.8k indexed · 1 hit paper · h-index 26
Topics
Traditional Chinese Medicine Analysis (13 papers)Ginseng Biological Effects and Applications (8 papers)Autophagy in Disease and Therapy (6 papers)

In The Last Decade

Kui Zhao

62 papers receiving 1.8k citations

Hit Papers

Modified acid polysaccharide derived from Salvia przewals...2024202620252024204060

Peers

Kui Zhao
Comparison fields: 5 of 122
  • Molecular Biology 773
  • Complementary and alternative medicine 556
  • Plant Science 305
  • Pharmacology 281
  • Pharmacology 228
Replace Fei Gao with:
Fei Gao China
Guanwei Fan China
Chun‐Hay Ko Hong Kong
Jiumao Lin China
Ruyuan Zhu China
Jianzhao Niu China
Tonghua Liu China
Zhejie Chen China
Longhuo Wu China
Miaomiao Jiang China
Kui Zhao relative to Fei Gao China Fei Gao's profile →
Citations per field
00.5×3.8×
Fei Gao · 1×
Citations per year

Countries citing papers authored by Kui Zhao

Since Specialization
Citations

This map shows the geographic impact of Kui Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kui Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kui Zhao more than expected).

Fields of papers citing papers by Kui Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kui Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kui Zhao. The network helps show where Kui Zhao may publish in the future.

Co-authorship network of co-authors of Kui Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Kui Zhao. A scholar is included among the top collaborators of Kui Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kui Zhao. Kui Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 29
5 2
6 24
7 33
8 47
9 1
10 30
11 13
12
Joint IDs Embedding and its Applications in E-commerce.
1
13 62
14 37
15 16
16 67
17 48
18 45
19 62
20 64

About Kui Zhao

Kui Zhao is a scholar working on Complementary and alternative medicine, Pharmacology and Health Informatics, having authored 65 papers that have together received 1.8k indexed citations. Recurring topics across this work include Traditional Chinese Medicine Analysis (13 papers), Ginseng Biological Effects and Applications (8 papers) and Autophagy in Disease and Therapy (6 papers). The work is most often cited by research in Complementary and alternative medicine (556 citations), Pharmacology (228 citations) and Pharmacology (281 citations). Kui Zhao has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Karl Wah Keung Tsim, Tina T. X. Dong, Jerry K.H. Cheung, Anna Cheung, Jun Li, Qiu Gao, Ran Duan, Luming Qi, Zhao Ji and Zhengjun Shi. Their work appears in journals such as ACS Nano, PLoS ONE and Nature Nanotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026